These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3772924)

  • 21. Collagen XVIII and fibronectin involvement in bullous scleroderma.
    Santos SN; Oliveira GV; Tavares AL; Massensini AR; Carvalhaes LM; Reljasvaara R; Kitten GT
    Dermatol Online J; 2005 Mar; 11(1):17. PubMed ID: 15748558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hsp60 in inflamed muscle tissue is the target of regulatory autoreactive T cells in patients with juvenile dermatomyositis.
    Elst EF; Klein M; de Jager W; Kamphuis S; Wedderburn LR; van der Zee R; Albani S; Kuis W; Prakken BJ
    Arthritis Rheum; 2008 Feb; 58(2):547-55. PubMed ID: 18240224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Plasma separation in severe juvenile dermatomyositis].
    Scharf JW; Michalk DV
    Monatsschr Kinderheilkd; 1985 Jan; 133(1):49-51. PubMed ID: 3974584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rituximab for the treatment of juvenile dermatomyositis: a report of four pediatric patients.
    Cooper MA; Willingham DL; Brown DE; French AR; Shih FF; White AJ
    Arthritis Rheum; 2007 Sep; 56(9):3107-11. PubMed ID: 17763414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vesiculo-bullous dermatomyositis: report of three cases.
    Nishigori K; Yamamoto T; Yokozeki H
    Dermatol Online J; 2009 Apr; 15(4):6. PubMed ID: 19450399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunopathological changes of micro-vessels in dermatomyositis].
    Shen GL; Lü H; Bi HY; Zhang W; Yao S; Tu P; Yuan Y
    Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(27):1912-5. PubMed ID: 17064530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TNFalpha-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications.
    Pachman LM; Liotta-Davis MR; Hong DK; Kinsella TR; Mendez EP; Kinder JM; Chen EH
    Arthritis Rheum; 2000 Oct; 43(10):2368-77. PubMed ID: 11037898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting the course of juvenile dermatomyositis: significance of early clinical and laboratory features.
    Stringer E; Singh-Grewal D; Feldman BM
    Arthritis Rheum; 2008 Nov; 58(11):3585-92. PubMed ID: 18975314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Juvenile linear scleroderma associated with serologic abnormalities.
    Woo TY; Rasmussen JE
    Arch Dermatol; 1985 Nov; 121(11):1403-5. PubMed ID: 3876808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical case of the month. 3-year-old boy presenting with a hand rash. Juvenile dermatomyositis.
    Kendrick CG; Poole JC; Nicotri T; Gedalia A; Lopez FA
    J La State Med Soc; 2004; 156(5):235-9; quiz 240. PubMed ID: 15554092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of specific autoantibodies in juvenile dermatomyositis.
    Feldman BM; Reichlin M; Laxer RM; Targoff IN; Stein LD; Silverman ED
    J Rheumatol; 1996 Oct; 23(10):1794-7. PubMed ID: 8895161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultraviolet light and cytoplasmic tubules in lupus erythematosus.
    Berk SH; Blank H
    Arch Dermatol; 1974 Mar; 109(3):364-6. PubMed ID: 4360831
    [No Abstract]   [Full Text] [Related]  

  • 33. Localized scleroderma in childhood is not just a skin disease.
    Zulian F; Vallongo C; Woo P; Russo R; Ruperto N; Harper J; Espada G; Corona F; Mukamel M; Vesely R; Musiej-Nowakowska E; Chaitow J; Ros J; Apaz MT; Gerloni V; Mazur-Zielinska H; Nielsen S; Ullman S; Horneff G; Wouters C; Martini G; Cimaz R; Laxer R; Athreya BH;
    Arthritis Rheum; 2005 Sep; 52(9):2873-81. PubMed ID: 16142730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis. Implications for diagnosis and therapy.
    Kimball AB; Summers RM; Turner M; Dugan EM; Hicks J; Miller FW; Rider LG
    Arthritis Rheum; 2000 Aug; 43(8):1866-73. PubMed ID: 10943878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Juvenile amyopathic dermatomyositis.
    Schmid MH; Trüeb RM
    Br J Dermatol; 1997 Mar; 136(3):431-3. PubMed ID: 9115933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three-dimensional imaging reveals major changes in skin microvasculature in lipoid proteinosis and lichen sclerosus.
    Kowalewski C; Kozłowska A; Chan I; Górska M; Woźniak K; Jabłońska S; McGrath JA
    J Dermatol Sci; 2005 Jun; 38(3):215-24. PubMed ID: 15927815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late recurrence of childhood dermatomyositis.
    Lovell HB; Lindsley CB
    J Rheumatol; 1986 Aug; 13(4):821-2. PubMed ID: 3772931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and serologic features of patients with polymyositis or dermatomyositis.
    Holden DJ; Brownell AK; Fritzler MJ
    Can Med Assoc J; 1985 Mar; 132(6):649-53. PubMed ID: 3872156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis.
    Wenzel J; Schmidt R; Proelss J; Zahn S; Bieber T; Tüting T
    Clin Exp Dermatol; 2006 Jul; 31(4):576-82. PubMed ID: 16716166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of subcutaneous fat in children with juvenile dermatomyositis.
    Verma S; Singh S; Bhalla AK; Khullar M
    Arthritis Rheum; 2006 Aug; 55(4):564-8. PubMed ID: 16874777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.